Calumet, INC /DE

Calumet, Inc. reported a second quarter 2026 net loss of $95.9 million, impacted by non-cash RINs and mark-to-market items, though Adjusted EBITDA with Tax Attributes reached $175.2 million.

Calumet, Inc. announced the results of its 2026 Annual Meeting of Stockholders, including the election of directors and the ratification of its independent auditor.

Calumet, Inc. reported a first quarter 2026 net loss of $317.0 million, impacted by non-cash items and operational downtime, though the company anticipates improved margins.

Jennifer Straumins will not seek re-election to Calumet's Board of Directors, retiring at the end of her current term.

Calumet, Inc. announced the closing of a $150 million private placement of 9.75% Senior Notes due 2031, with proceeds earmarked for revolving credit facility repayment.

Calumet, Inc. announced the pricing of $150 million in 9.75% Senior Notes due 2031 in a private placement, with proceeds intended to repay its revolving credit facility.

Calumet, Inc. reported a net loss of $95.9 million for Q2 2026, impacted by derivative losses and RINs expenses, though sales increased significantly due to higher prices and volumes.

Calumet, Inc. reported a net loss of $317.0 million for Q1 2026, impacted by non-cash charges and production issues, while securing a limited waiver from the DOE.

Calumet, Inc. reported a significant turnaround in net income for Q3 2025, driven by improved commodity margins and strategic advancements in its Montana Renewables segment, despite a material weakness in internal controls.

Calumet, Inc. filed an amended quarterly report for Q2 2025, restating financial statements due to cash flow misclassifications stemming from a material weakness in internal controls.

Calumet, Inc. has amended its Q1 2025 financial report to correct cash flow misclassifications and disclosed a material weakness in internal controls, while reporting an increased net loss despite operational improvements.

Calumet, Inc. reported a widened net loss and negative gross profit in Q2 2025, primarily impacted by increased RINs obligations and mark-to-market losses, despite operational improvements and strategic debt management.

Calumet, Inc. reported a significant reduction in net loss and increased Adjusted EBITDA in 2025, fueled by strong operational performance in its Specialty Products and Solutions and Montana/Renewables segments.

Calumet, Inc.'s 2024 10-K filing reveals a year of strategic shifts, including a corporate conversion and significant investments in renewable fuels, alongside challenges in commodity markets.

John G. Boss, a Director of Calumet, Inc. /DE, reported multiple transactions in common stock on July 9, 2026.

Stephen P Mawer, a Director of Calumet, Inc. /DE, reported multiple transactions in common stock on July 9, 2026.

Paul C Raymond, a Director of Calumet, Inc. /DE, reported multiple transactions in common stock on July 9, 2026.

Daniel J Sajkowski, a Director of Calumet, Inc. /DE, reported multiple transactions in common stock on July 9, 2026.

Amy M Schumacher, a Director of Calumet, Inc. /DE, reported multiple transactions in common stock on July 9, 2026.

Julio M Quintana, a Director of Calumet, Inc. /DE, reported multiple transactions in common stock on July 9, 2026.

Calumet, Inc. outlines 2025 financial performance, executive compensation redesign, and strategic growth initiatives ahead of its 2026 Annual Meeting.

Calumet, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to Section 14(a) of the Securities Exchange Act of 1934.

Calumet, Inc. will hold its inaugural Annual Meeting of Stockholders on June 10, 2025, and the proxy statement details key proposals, director nominees, and executive compensation.

A group of investors led by Wasserstein Debt Opportunities Management, L.P. and Rajay Bagaria has disclosed a significant 7.0% beneficial ownership stake in Calumet, Inc., citing undervaluation and intentions to engage with management on corporate governance and board composition.

Investment firm Two Seas Capital LP, along with its GP and chief investment officer Sina Toussi, has reported beneficial ownership of 7.5% of Calumet, Inc.'s common stock as of June 30, 2026.

Wasserstein entities and individuals update beneficial ownership of Calumet Inc. common stock, reporting a combined 4.6% stake.

Adams Asset Advisors, LLC filed an amendment to its Schedule 13G, reporting a reduction in its beneficial ownership of Calumet, Inc. common stock to 4.68%.

The Vanguard Group has filed an amended Schedule 13G, reporting a 0% beneficial ownership in Calumet Inc following an internal realignment.

Two Seas Capital LP, along with its affiliates, has reported a 7.8% beneficial ownership stake in Calumet, Inc., totaling 6,752,538 shares as of September 30, 2025.

Two Seas Capital LP, along with its general partner and chief investment officer, has disclosed a 5.2% beneficial ownership stake in Calumet, Inc. as of June 30, 2025.